n-methyl-3,4-methylenedioxyamphetamine has been researched along with nociceptin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BastÃas Candia, Sdel C; Candeletti, S; Cavina, C; D'Addario, C; Di Benedetto, M; Porticella, EE; Romualdi, P | 1 |
Candeletti, S; Caputi, FF; Carboni, L; Palmisano, M; Romualdi, P | 1 |
2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and nociceptin
Article | Year |
---|---|
Regulation of opioid gene expression in the rat brainstem by 3,4-methylenedioxymethamphetamine (MDMA): role of serotonin and involvement of CREB and ERK cascade.
Topics: Animals; Blotting, Western; Brain Stem; Cyclic AMP Response Element-Binding Protein; Enkephalins; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nociceptin; Opioid Peptides; Phosphorylation; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT2; Reverse Transcriptase Polymerase Chain Reaction; Serotonin; Serotonin Antagonists; Signal Transduction | 2011 |
Opioid gene expression changes and post-translational histone modifications at promoter regions in the rat nucleus accumbens after acute and repeated 3,4-methylenedioxy-methamphetamine (MDMA) exposure.
Topics: Adrenergic Uptake Inhibitors; Animals; Dynorphins; Gene Expression Regulation; Histone Code; Locomotion; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nociceptin; Nucleus Accumbens; Opioid Peptides; Promoter Regions, Genetic; Rats, Sprague-Dawley; Serotonin Agents | 2016 |